BiotechnologyGet all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.May 16, 2020, 10:26 ETAUA Abstracts Further Support Role for Cysview® in the Office Setting

Photocure ASA (OSE: PHO) today announced key data was published by the 2020 American Urological Association (AUA) Annual Virtual Meeting. Three...

May 15, 2020, 18:41 ETCoronavirus (COVID-19) Update: Daily Roundup

The U.S. Food and Drug Administration today continued to take action in the ongoing response effort to the COVID-19 pandemic: Today, the FDA issued...

May 15, 2020, 17:35 ETINVO Bioscience Reports First Quarter 2020 Financial Results

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

May 15, 2020, 16:30 ETCardax Reports Q1 2020 Results

Cardax, Inc. (OTCQB:CDXI) reported its Q1 2020 results. Highlights: Financial Results. Net losses from the same quarter last year decreased 11.7%,...

May 15, 2020, 16:30 ETPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on May 11, 2020 it approved non-statutory stock options to purchase an aggregate of 50,025 ...

May 15, 2020, 16:10 ETProteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of...

May 15, 2020, 16:05 ETBioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020

BioPharmX Corporation (NYSE American: BPMX) ( BioPharmX or the Company ), a specialty pharmaceutical company focused on developing innovative...

May 15, 2020, 13:45 ETGlobal Biomedical Sensor Market Forecast to Reach $18.90 Billion by 2026, Growing at a CAGR of 8.0% from 2018 to 2026

The Global Biomedical Sensor Market Analysis 2020 report has been added to ResearchAndMarkets.com\'s offering. The Global Biomedical Sensor market...

May 15, 2020, 13:00 ETI Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service

I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up focusing on Nobel Prize-wining technology induced pluripotent stem cell (iPSC) ...

May 15, 2020, 11:00 ETEconomic Downturn To Continue Through 2020

The economic downturn in the U.S. will continue for the rest of 2020, say the nation\'s purchasing and supply executives in the Spring 2020 Semiannual ...

May 15, 2020, 09:36 ETNew Data Uncover Potential of Expedited Pathway for Immunotherapy Development Through CAR Monocytes

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, shares details from new data ...

The global biomaterials market is set to gain impetus from the increasing usage of a wide variety of biomaterials because of their clinical...

May 15, 2020, 08:47 ETQuanta Names Francisco Ortiz as Head of Sales

Quanta, Inc. (OTCPK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of...

May 15, 2020, 08:30 ETSenesTech Announces First Quarter 2020 Financial and Operational Results

SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility...

May 15, 2020, 08:30 ETAbbVie Data at EHA Annual Congress Highlight Depth and Breadth of Transformative Blood Cancer Portfolio

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it will present data from studies evaluating the BCL-2...

May 15, 2020, 08:30 ETAmyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format

Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands...

GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to-treat cancers, today announced...

May 15, 2020, 08:00 ETLipocine Announces Presentations on TLANDO™ at AUA Virtual Experience 2020

Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that clinical...

GEMoaB, une société de produits biopharmaceutiques qui se consacre au développement d\'immunothérapies de nouvelle génération contre les cancers...

GEMoaB, ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Immuntherapien der nächsten Generation im Bereich schwer behandelbarer...